Automated processing of paper-based prior authorizations. We are able to ingest any paper form, semantically understand the content, extract entities, and feed those to your downstream systems via API. Our end-to-end proprietary pipeline is tuned to the language and processes of healthcare, insurance and banking. The result? Consistent quality that is better than human.

State of the Art Natural Language Processing for payers and providers. Our technical founder was a top researcher at Facebook AI Research, and our team is backed by the leading NLP research institute in the country, The Allen Institute for Artificial Intelligence.

• Cohere Unify™ Intake: Digitizing and improving intake across fax, EMR, and portal
• Cohere Unify™ Decisioning: Prior authorization check, completeness scan, automated clinical review, and pended review pre-processing
• Cohere Unify™ Review: Queue management, AI-assisted manual review, and letter generation

Cohere Health is a clinical intelligence company that provides intelligent prior authorization as a springboard to better quality outcomes by aligning physicians and health plans on evidence-based care paths for the patient's entire care journey. Cohere's intelligent prior authorization solutions reduce administrative expenses while improving patient outcomes. The company is a winner of the TripleTree iAward and has been named to both Fierce Healthcare's Fierce 15 and CB Insights' Digital Health 150 lists. Cohere's investors include Flare Capital Partners, Define Ventures, Deerfield, Polaris Partners, and Longitude Capital.

The only UM platform designed to support in-house operations, or fully-delegated programs.

Whether a health plan is seeking to innovate their in-house UM operations or outsource utilizing a vendor partner for key service lines, Cohere is uniquely positioned to partner with them to build a path from digital transformation to true care collaboration.

1. 25-40% reduction of administrative costs
2. 65 NPS score among providers
3. 70% faster access to patient care
4. 15%+ medical cost savings beyond incumbent programs